Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
CVRx, Inc. | VP OF GLOBAL CLINICAL RESEARCH | Common Stock | 778 | $14.4K | $18.55 | Oct 16, 2023 | Direct |
CVRx, Inc. | VP OF GLOBAL CLINICAL RESEARCH | Stock Option (right to buy) | 0 | $5.14 | Oct 16, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CVRX | CVRx, Inc. | Oct 16, 2023 | 2 | $184 | 4 | Oct 18, 2023 | VP OF GLOBAL CLINICAL RESEARCH |
CVRX | CVRx, Inc. | Jan 18, 2023 | 1 | $0 | 4 | Jan 20, 2023 | VP OF GLOBAL CLINICAL RESEARCH |
CVRX | CVRx, Inc. | Aug 2, 2022 | 1 | $0 | 4 | Aug 4, 2022 | VP OF GLOBAL CLINICAL RESEARCH |
CVRX | CVRx, Inc. | Jan 18, 2022 | 1 | $0 | 4 | Jan 20, 2022 | VP of Global Clinical Research |
CVRX | CVRx, Inc. | Jun 29, 2021 | 1 | $0 | 4 | Jul 1, 2021 | VP of Global Clinical Research |
CVRX | CVRx, Inc. | Jun 29, 2021 | 0 | $0 | 3 | Jun 29, 2021 | VP of Global Clinical Research |